Storia in 2 fonti

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Darolutamide offers 'an option for preserving cognitive health' in advanced disease, expert says

Raccontata da

healio.com

medpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 mesi fa

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Darolutamide offers 'an option for preserving cognitive health' in advanced disease, expert says

originale

healio.com1 mesi fa

‘Clearly different’: Cognitive effects vary by treatment in advanced prostate cancer

CHICAGO — The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they receive, according to randomized phase 2 trial results presented at ASCO Annual Meeting.An…

Leggi questa versione → originale

Timeline cronologica

venerdì 22 maggio 2026·healio.com
‘Clearly different’: Cognitive effects vary by treatment in advanced prostate cancer
CHICAGO — The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they receive, according to randomized phase 2 trial…
venerdì 22 maggio 2026·medpagetoday.com
Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline
Darolutamide offers 'an option for preserving cognitive health' in advanced disease, expert says